-
FDA approves new dosage strength for Purdue Pharma's Butrans
STAMFORD, Conn. — The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.
Purdue announced the approval of the 15-microgram-per-hour strength of Butrans (buprenorphine). The drug is used to treat moderate to severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. The new strength is in addition to the 5-microgram, 10-microgram and 20-microgram strengths already on the market, and it will be launched next month.
-
Abbott launches Glucerna Advance RTD to provide nutritional benefits for those with diabetes
ABBOTT PARK, Ill. — Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system, Abbott noted.